Analysis of a Modified Version of the Inventory of Non‐Ataxia Signs Over 12 Years in Patients with Friedreich's Ataxia in the <scp>EFACTS</scp> Study

The modified INAS sum showed good responsiveness over 5 years but not over 1-3 years. It may supplement existing outcome measures, contributing to holistic assessment of this multisystem disease, especially in non-ambulatory patients, in whom ataxia-focused measures may show ceiling effects, and children, who typically progress faster. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Authors

Institutions

Publication Details

Journal
Movement Disorders
Published
2025-10-10
DOI
https://doi.org/10.1002/mds.70084
Primary Topic
Genetic Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Analysis of a Modified Version of the Inventory of Non‐Ataxia Signs Over 12 Years in Patients with Friedreich's Ataxia in the EFACTS Study

Myriam Rai, Stella A. Glasmacher, Imis Dogan, Wolfgang Nachbauer et al.
Movement Disorders
Genetic Neurodegenerative Diseases
article

Analysis of a Modified Version of the Inventory of Non‐Ataxia Signs Over 12 Years in Patients with Friedreich's Ataxia in the EFACTS Study

Myriam Rai, Stella A. Glasmacher, Imis Dogan, Wolfgang Nachbauer, Claire Ewenczyk, Thomas Klopstock, R.-D Hilgers, Alexandra Dürr, Jörg B. Schulz, Thomas Klockgether, Caterina Mariotti, Kathrin Reetz, Zofia Fleszar, Michael Parkinson, Paola Giunti, Sylvia Boesch, Marcus Grobe‐Einsler, Heike Jacobi, Claudia Stendel, Ludger J. Schöls, Massimo Pandolfo, Francisco Javier Rodríguez de Rivera Garrido, Ilaria Giordano
article en

Abstract

The modified INAS sum showed good responsiveness over 5 years but not over 1-3 years. It may supplement existing outcome measures, contributing to holistic assessment of this multisystem disease, especially in non-ambulatory patients, in whom ataxia-focused measures may show ceiling effects, and children, who typically progress faster. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Movement DisordersVol. 41(1)
Centre National de la Recherche Scientifique (FR), Université Libre de Bruxelles (BE), Innsbruck Medical University (AT), Inserm (FR), Forschungszentrum Jülich (DE), Heidelberg University (DE), University Hospital Bonn (DE), Hospital Universitario La Paz (ES), German Center for Neurodegenerative Diseases (DE), Sorbonne Université (FR), Hospital La Paz Institute for Health Research (ES), Munich Cluster for Systems Neurology (DE), Friedrich Baur Stiftung (DE), Friedreich's Ataxia Research Alliance (US), Hertie Institute for Clinical Brain Research (DE), National Hospital for Neurology and Neurosurgery (GB), Institut du Cerveau (FR), Fondazione IRCCS Istituto Neurologico Carlo Besta (IT), University College London (GB), University of Tübingen (DE), Ludwig-Maximilians-Universität München (DE), RWTH Aachen University (DE)
Eli Lilly and Company, Biogen, Eisai, Ipsen
Openalex Percentile: Top 69%
Genetic Neurodegenerative Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.